Overview

Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetic (PK) properties of various modified release tablet formulations of Lu AF11167 (Part A) and to investigate the pharmacokinetic (PK) properties of a modified release tablet formulation of Lu AF11167 in a fed and fasted state and following multiple dosing (Part B).
Phase:
Phase 1
Details
Lead Sponsor:
H. Lundbeck A/S